Evidence map›Paper›PMID 36967820›Full record

SynthesisFrontiers in aging neuroscience2023

Effectiveness of non-pharmacological therapies on cognitive function in patients with dementia-A network meta-analysis of randomized controlled trials.

Guangxin Luo, Junqiu Zhang, Zeyi Song, Ying Wang, Xiaojing Wang, Haifeng Qu, Fang Wang, Chengjiang Liu, Fujia Gao

Registry-linked trialOpen access · goldFull text readSystematic Review
In one paragraph

Synthesis in Frontiers in aging neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07224607 (A Longitudinal Study Investigating the Effects of Photobiomodulation), which is not on this map. Cited by 25 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 4 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07224607 narecruitingnot on this mapstarted 2025, after this paper: background citation

A Longitudinal Study Investigating the Effects of Photobiomodulation (PBM) on Cognitive Function and Alzheimer's Disease (AD)-Related Biomarkers in Individuals With Mild Cognitive Impairment (MCI) or Dementia Due to AD

TypeinterventionalSponsorCedars-Sinai Medical CenterRan2025 to 2026Enrolled45ConditionsAlzheimer's DiseaseArmsPhotobiomodulation
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 4 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Guangxin LuoSchool of Public Health, North China University of Science and Technology, Tangshan, China.
Junqiu ZhangSchool of Public Health, North China University of Science and Technology, Tangshan, China.
Zeyi SongSchool of Clinical Medicine, North China University of Science and Technology, Tangshan, China.
Ying WangSchool of Public Health, North China University of Science and Technology, Tangshan, China.
Xiaojing WangSchool of Public Health, North China University of Science and Technology, Tangshan, China.
Haifeng QuSchool of Clinical Medicine, North China University of Science and Technology, Tangshan, China.
Fang WangDepartment of Psychology, The Fourth People's Hospital of Wuhu, Wuhu, China.
Chengjiang LiuDepartment of General Medicine, Affiliated Anqing First People's Hospital of Anhui Medical University, Anqing, China.
Fujia GaoSchool of Public Health, North China University of Science and Technology, Tangshan, China.
North China University of Science and Technology · CNAnqing City Hospital · CNThe Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Non-pharmacological therapies (NPTs) have received increasing attention from researchers as a category of treatment to improve cognitive impairment in patients with dementia because of their fewer side effects. In this study, photobiomodulation (PBM), enriched environment (EE), exercise therapy (ET), computerized cognitive training (CCT), and cognitive stimulation therapy (CST) were selected to compare the effects of NPTs that improve dementia by quantifying information from randomized controlled trials (RCTs). Methods: We did a systematic review and network meta-analysis. We searched PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), China National Knowledge Infrastructure Database, Wan Fang Database, Chinese Biomedical Literature Database, Web of Science, and VIP Database from the time of database creation to 1 August 2022. Two investigators independently screened the literature, extracted information, and assessed the RCTs' quality with the Cochrane Collaboration Network Risk of Bias 2.0. Network meta-analysis was performed using R language (X64 version 4.1.3) and STATA 17.0. Results: We identified 1,268 citations and of these included 38 trials comprising 3,412 participants. For improving dementia, the results of the network meta-analysis showed that compared with the control group (CON), PBM (SMD = 0.90, 95% CI: 0.43-1.37), EE (SMD = 0.71, 95% CI: 0.02-1.41), ET (SMD = 0.42, 95% CI: 0.16-0.68), and CST (SMD = 0.36, 95% CI: 0.11-0.62) were significantly different ( Conclusion: In this study, NPTs have excellent potential to improve cognition in people with dementia, and PBM may have more significant benefits in improving cognition than the other four NPTs. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42022363746.

Indexed as

cognitivedementianetwork meta-analysisnon-pharmacological therapyrandomized controlled trials

Identifiers

PMID36967820
PMCPMC10035791
OpenAlexW4322772893

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read40
measurements read12
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.